Association of SGLT2 Inhibitor With Stroke in Type 2 Diabetes With Diabetic Retinopathy: A Multicenter Electronic Health Record Data Study

Key Points

• To investigate the association of SGLT2 inhibitors with stroke risk in type 2 diabetes patients with diabetic retinopathy.
• Multicenter study utilizing electronic health records.
• Analysis focused on patients with type 2 diabetes and diabetic retinopathy.
• Comparison of stroke incidence between those using SGLT2 inhibitors and those not.
• SGLT2 inhibitors associated with a lower risk of stroke, particularly hemorrhagic stroke.
• Findings indicate a potential cerebrovascular benefit for this medication class.

Abstract